Skip to main content
See every side of every news story
Published loading...Updated

FDA Approves Long-Lasting OTC Pain Reliever Combining Acetaminophen and Naproxen

Kenvue says the fixed-dose medicine starts working within 30 minutes and lasts up to 12 hours, offering a non-opioid option for minor pain.

  • The Food and Drug Administration approved an over-the-counter pain medication combining Tylenol and Aleve, offering patients a single fixed-dose alternative for minor aches and pains.
  • Kenvue designed the medication to combine fast-acting Tylenol with the longer-lasting effects of Naproxen; eight clinical studies showed superior pain relief compared to either ingredient alone.
  • The medication begins working within 30 minutes and provides relief for up to 12 hours, indicated for adults and children 12 and older treating minor aches.
  • Kenvue received three years of market exclusivity for the new drug, coinciding with Kimberly-Clark's $48.7 billion acquisition of the Tylenol manufacturer.
  • The FDA stated the approval aligns with the Trump administration's "Great Healthcare Plan," intended to expand access to safe over-the-counter medications, with the product available soon.
Insights by Ground AI

11 Articles

Lean Left

Authorization is part of Trump's "Big Medical Care Plan," which seeks to facilitate access to safe, non-prescription medications

·Los Angeles, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 90% of the sources are Center
90% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medical Daily broke the news on Thursday, July 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal